Back to search
FDAFDA · Food and drugs·Recall number Z-2811-2026

EOPA 3D Arterial Cannula 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 78322

Published August 5, 2026 · Recall initiated: June 24, 2026

Summary

FDA records medical device Class II recall Z-2811-2026, published August 5, 2026 and initiated June 24, 2026. Recalling firm: Medtronic Perfusion Systems; Status: Ongoing; Reported quantity: 1,424 units; Lot: UDI-DI: 20199150023251, Lot Numbers: 0232709184 0232745036 0232798416 0232862784 0232862787; UDI-DI: 00199150023257, Lot Numbers: 0232862787. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ dysfunction.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Perfusion Systems
Distributor
Worldwide - US Nationwide distribution.
Lot
UDI-DI: 20199150023251, Lot Numbers: 0232709184 0232745036 0232798416 0232862784 0232862787; UDI-DI: 00199150023257, Lot Numbers: 0232862787
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was EOPA 3D Arterial Cannula 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 78322 recalled?

Yes. FDA published recall Z-2811-2026 on August 5, 2026. Reported hazard: Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ dysfunction.

What should I do if I have this product?

Voluntary: Firm initiated · Letter